Indapta Therapeutics
Drug DiscoveryWebsite
Indapta Therapeutics valuation and funding history | Last updated: October 10, 2025 | 2 funding rounds
Current Valuation
N/A
As of October 10, 2025
Total Funding Raised
$162.3M
Across 2 rounds
Last Round
Later Stage VC
$50.8M
Last Funding
Oct 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| December 17, 2024 | Later Stage VC | $22.5M | N/A | - |
| May 18, 2023 | Later Stage VC (Series A) | $80.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Indapta Therapeutics is currently valued at N/A as of October 10, 2025. The company has raised a total of $162.3M in funding across 2 funding rounds.
What is Indapta Therapeutics Worth in 2026?
Indapta Therapeutics is a leading private company in the Drug Discovery sector. Track Indapta Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Indapta Therapeutics Valuation is Determined
Private company valuations like Indapta Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.